Antibody data
- Antibody Data
- Antigen structure
- References [6]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- V2571 - Provider product page
- Provider
- NSJ Bioreagents
- Product name
- HLA-A Antibody (MHC I)
- Antibody type
- Monoclonal
- Description
- This highly specific HLA-A antibody is suitable for use in Flow cytometry/Immunofluorescence applications with human samples.
- Reactivity
- Human
- Host
- Mouse
- Conjugate
- Unconjugated
- Antibody clone number
- 108-2C5
- Vial size
- 20 ug (with BSA and sodium azide), 100 ug (with BSA and sodium azide), 100 ug (without BSA or sodium azide), 7 ml IHC only format (if applicable)
- Concentration
- 0.2 mg/ml, 1 mg/ml
- Storage
- Store the HLA-A antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).
Submitted references Endoplasmic Reticulum Aminopeptidase 1 (ERAP1) Polymorphism Relevant to Inflammatory Disease Shapes the Peptidome of the Birdshot Chorioretinopathy-Associated HLA-A*29:02 Antigen.
Induction of regular cytolytic T cell synapses by bispecific single-chain antibody constructs on MHC class I-negative tumor cells.
Major histocompatibility complex class I expression in human tonsillar and laryngeal epithelium.
Control of T-cell-mediated immune response by HLA class I in human pancreatic carcinoma.
Loss of heterozygosity in the HLA class I region in human pancreatic cancer.
Antigenicity of HLA-A2 and HLA-B7. Loss and gain of serologic determinants induced by site-specific mutagenesis at residues 62 to 80.
Alvarez-Navarro C, Martín-Esteban A, Barnea E, Admon A, López de Castro JA
Molecular & cellular proteomics : MCP 2015 Jul;14(7):1770-80
Molecular & cellular proteomics : MCP 2015 Jul;14(7):1770-80
Induction of regular cytolytic T cell synapses by bispecific single-chain antibody constructs on MHC class I-negative tumor cells.
Offner S, Hofmeister R, Romaniuk A, Kufer P, Baeuerle PA
Molecular immunology 2006 Feb;43(6):763-71
Molecular immunology 2006 Feb;43(6):763-71
Major histocompatibility complex class I expression in human tonsillar and laryngeal epithelium.
Hobbs CG, Rees LE, Heyderman RS, Birchall MA, Bailey M
Clinical and experimental immunology 2006 Aug;145(2):365-71
Clinical and experimental immunology 2006 Aug;145(2):365-71
Control of T-cell-mediated immune response by HLA class I in human pancreatic carcinoma.
Ryschich E, Nötzel T, Hinz U, Autschbach F, Ferguson J, Simon I, Weitz J, Fröhlich B, Klar E, Büchler MW, Schmidt J
Clinical cancer research : an official journal of the American Association for Cancer Research 2005 Jan 15;11(2 Pt 1):498-504
Clinical cancer research : an official journal of the American Association for Cancer Research 2005 Jan 15;11(2 Pt 1):498-504
Loss of heterozygosity in the HLA class I region in human pancreatic cancer.
Ryschich E, Cebotari O, Fabian OV, Autschbach F, Kleeff J, Friess H, Bierhaus A, Büchler MW, Schmidt J
Tissue antigens 2004 Dec;64(6):696-702
Tissue antigens 2004 Dec;64(6):696-702
Antigenicity of HLA-A2 and HLA-B7. Loss and gain of serologic determinants induced by site-specific mutagenesis at residues 62 to 80.
Doménech N, Santos-Aguado J, López de Castro JA
Human immunology 1991 Feb;30(2):140-6
Human immunology 1991 Feb;30(2):140-6
No comments: Submit comment
No validations: Submit validation data